Lv1
10 积分 2025-03-07 加入
Siglec-15 as an Emerging Target for Next-generation Cancer Immunotherapy
4天前
已完结
Siglec-15: an immune system Siglec conserved throughout vertebrate evolution
4天前
已完结
Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting
5天前
已关闭
Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of
1个月前
已完结
Preclinical evaluation of (177)lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors
1个月前
已完结
Preclinical evaluation of (177)lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors
1个月前
已关闭
Siglec-15 binds mucin-domain glycoproteins with extended glycans and marks an osteoclast-like, matrix remodeling myeloid state in human tumors
1个月前
已完结
The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF- secretion from monocytes/macrophages through the DAP12-Syk pathway
1个月前
已完结
Siglec‐15 promotes the migration of liver cancer cells by repressing lysosomal degradation of CD44
2个月前
已完结
The Role of Siglec-15 in Tumor Immunity: Mechanisms and Therapy
2个月前
已完结
皖公网安备34019202002308
